IL308171A - Contraceptive compounds and methods - Google Patents
Contraceptive compounds and methodsInfo
- Publication number
- IL308171A IL308171A IL308171A IL30817123A IL308171A IL 308171 A IL308171 A IL 308171A IL 308171 A IL308171 A IL 308171A IL 30817123 A IL30817123 A IL 30817123A IL 308171 A IL308171 A IL 308171A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- contraceptive compounds
- contraceptive
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003433 contraceptive agent Substances 0.000 title 1
- 230000002254 contraceptive effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184014P | 2021-05-04 | 2021-05-04 | |
| US202263307943P | 2022-02-08 | 2022-02-08 | |
| US202263326524P | 2022-04-01 | 2022-04-01 | |
| PCT/US2022/027506 WO2022235693A1 (en) | 2021-05-04 | 2022-05-03 | Contraceptive compounds and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL308171A true IL308171A (en) | 2023-12-01 |
Family
ID=81854578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL308171A IL308171A (en) | 2021-05-04 | 2022-05-03 | Contraceptive compounds and methods |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11780828B2 (https=) |
| EP (1) | EP4334309A1 (https=) |
| JP (1) | JP7828661B2 (https=) |
| KR (1) | KR20240004737A (https=) |
| AU (1) | AU2022270088A1 (https=) |
| CA (1) | CA3217096A1 (https=) |
| IL (1) | IL308171A (https=) |
| MX (1) | MX2023012958A (https=) |
| WO (1) | WO2022235693A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7828661B2 (ja) * | 2021-05-04 | 2026-03-12 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 避妊薬の化合物及び方法 |
| WO2025251031A1 (en) * | 2024-05-30 | 2025-12-04 | Yourchoice Therapeutics, Inc. | Contraceptive compounds and dosing for the same |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4559157A (en) | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
| LU84979A1 (fr) | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
| US4820508A (en) | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
| US4992478A (en) | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| CN1255396C (zh) * | 1996-03-18 | 2006-05-10 | 卫材株式会社 | 含有稠环的羧酸衍生物 |
| US7105566B2 (en) * | 2002-10-22 | 2006-09-12 | Allergan, Inc. | Methods of treatment during vascular procedures |
| AU2015365738B2 (en) * | 2014-12-19 | 2020-07-23 | Galderma Research & Development | Novel compounds, synthesis method thereof and use of same in medicine and in cosmetics |
| WO2017201200A1 (en) * | 2016-05-19 | 2017-11-23 | Orphagen Pharmaceuticals, Inc. | Therapeutic compositions containing rar-alpha antagonists |
| WO2019014468A1 (en) * | 2017-07-13 | 2019-01-17 | Io Therapeutics, Inc. | RECEPTOR SUBTYPE AND RETINOID COMPOUNDS AND SELECTIVE REXINOIDS OF A FUNCTION IN COMBINATION WITH IMMUNE MODULATORS FOR ANTICANCER IMMUNOTHERAPY |
| EP3709990A4 (en) * | 2017-11-17 | 2021-12-01 | The Regents of the University of California | MANIPULATION OF THE RETIC ACID SIGNAL PATH |
| JP7828661B2 (ja) * | 2021-05-04 | 2026-03-12 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 避妊薬の化合物及び方法 |
-
2022
- 2022-05-03 JP JP2023567167A patent/JP7828661B2/ja active Active
- 2022-05-03 AU AU2022270088A patent/AU2022270088A1/en active Pending
- 2022-05-03 MX MX2023012958A patent/MX2023012958A/es unknown
- 2022-05-03 EP EP22726863.8A patent/EP4334309A1/en active Pending
- 2022-05-03 CA CA3217096A patent/CA3217096A1/en active Pending
- 2022-05-03 IL IL308171A patent/IL308171A/en unknown
- 2022-05-03 KR KR1020237041162A patent/KR20240004737A/ko active Pending
- 2022-05-03 WO PCT/US2022/027506 patent/WO2022235693A1/en not_active Ceased
- 2022-05-03 US US17/735,918 patent/US11780828B2/en active Active
-
2023
- 2023-08-11 US US18/233,090 patent/US12281105B2/en active Active
-
2025
- 2025-03-21 US US19/087,102 patent/US20250276962A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250276962A1 (en) | 2025-09-04 |
| US20220388993A1 (en) | 2022-12-08 |
| US12281105B2 (en) | 2025-04-22 |
| AU2022270088A1 (en) | 2023-11-23 |
| EP4334309A1 (en) | 2024-03-13 |
| KR20240004737A (ko) | 2024-01-11 |
| CA3217096A1 (en) | 2022-11-10 |
| JP7828661B2 (ja) | 2026-03-12 |
| MX2023012958A (es) | 2024-01-05 |
| JP2024516023A (ja) | 2024-04-11 |
| US11780828B2 (en) | 2023-10-10 |
| US20240109872A1 (en) | 2024-04-04 |
| WO2022235693A1 (en) | 2022-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL296357B1 (en) | Heterocyclic pyrimido compounds and their uses | |
| IL277232A (en) | Intravaginal support devices and methods | |
| PL4117594T3 (pl) | Układy i sposoby wspomagania mobilności | |
| PL3858833T3 (pl) | Pochodna aminonorbornanu oraz sposób jej wytwarzania i zastosowanie | |
| GB202019767D0 (en) | Compostitions and methods | |
| GB202015044D0 (en) | New compounds and methods | |
| GB202015035D0 (en) | New compounds and methods | |
| IL308171A (en) | Contraceptive compounds and methods | |
| CA198607S (en) | Contraceptive | |
| IL309878A (en) | Therapeutic compounds and methods | |
| EP4458987A4 (en) | BCH1X HELICASE AND ITS USE | |
| GB202113594D0 (en) | New compounds and methods | |
| GB2611187B (en) | Use and method | |
| IL311521A (en) | Compounds targeting EGFRVIII and their uses | |
| GB202113588D0 (en) | New compounds and methods | |
| GB2609814B (en) | Terpenophenolic compounds and their use | |
| GB202104122D0 (en) | Compounds and their use | |
| GB202109069D0 (en) | Compounds and method | |
| GB202106040D0 (en) | Methods and uses | |
| GB202103872D0 (en) | Uses and methods | |
| GB202019660D0 (en) | Uses and methods | |
| GB202004486D0 (en) | Flushing devices and methods | |
| HK40101249A (en) | Contraceptive compounds and methods | |
| GB202109478D0 (en) | Compounds and methods | |
| CA217761S (en) | Condom |